Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Water-Soluble Peptides with Stable Helical Structure Are Potential Nanoparticle Carriers

By LabMedica International staff writers
Posted on 15 Mar 2011
A paper describes the synthesis of peptides with stable helical structure that may serve as nanoparticle carriers for drug and gene delivery.

Water-soluble peptides with stable helical structure are of interest to protein chemists because of their importance in basic science and their broad utility in medicine and biotechnology. More...
Incorporating charged amino-acid residues to improve peptide solubility, however, usually leads to reduced helical stability because of increased side-chain charge repulsion, reduced side-chain hydrophobicity, and the disruption of intramolecular hydrogen bonding.

In the current study, published in the February 22, 2011, online edition of the journal Nature Communications, investigators at the University of Illinois (Urbana-Champaign, USA) showed that water-soluble, ultra-stable alpha-helical polypeptides could be produced by elongating charge-containing amino-acid side chains to position the charges far removed from the polypeptide backbone. As the length of the side chains with charges on the end increased, the tendency of the polypeptides to form helices also increased. The helices prepared by this method displayed remarkable stability even when compared to noncharged helices and were resistant to temperature, pH, and other denaturing agents that would denature most polypeptides.

"You can achieve the helical structure and the solubility but you have to design the helical structure in a very special way. The peptide design needs a very specific sequence. Then you are very limited in the type of polypeptide you can build, and it is not easy to design or handle these polypeptides,” said senior author Dr. Jianjun Cheng, professor of materials science and engineering at the University of Illinois. "It is such a simple idea – move the charge away from the backbone. It is not difficult at all to make the longer side chains, and it has amazing properties for winding up helical structures simply by pushing the distance between the charge and the backbone.”

"We want to test the correlation of the lengths of the helices and the circulation in the body to see what is the impact of the shape and the charge and the side chains for clearance in the body,” said Dr. Cheng. "Recent studies show that the aspect ratio of the nanostructures – spherical structures versus tubes – has a huge impact on their penetration of tumor tissues and circulation half-lives in the body.”

Related Links:

University of Illinois




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.